3652 results for «231»
3652 results
Abstracts session 1
10 Dec 2025 – From GulfPCR-GIM 2025
This abstracts session presents contemporary research and clinical insights in interventional cardiology, covering topics such as colchicine therapy post-stenting, ranolazine use in chronic coronary syndrome, artificial intelligence applications in quantitative coronary analysis, and optimization techniques in transcatheter aortic valve implantation. It also explores novel predictors of...
Tricuspid repair or replacement - Matching the patient to the procedural strategy
17 Nov 2025 – From PCR London Valves 2025
This session addresses the nuanced decision-making process in selecting appropriate transcatheter tricuspid repair or replacement strategies. It covers the current device landscape, patient selection criteria based on anatomical and clinical factors, and discusses emerging challenges such as pacing lead management, anticoagulation, and outcome definitions.
Alain Cribier EuroIntervention Award
16 Nov 2025 – From PCR London Valves 2025
This session honors the legacy and contributions of Alain Cribier through the EuroIntervention Award, recognizing excellence and innovation in interventional cardiology. It reflects on the advancements inspired by Dr. Cribier's pioneering work and highlights key achievements in the field.
Special Recognition Award Ceremony
17 Nov 2025 – From PCR London Valves 2025
The Special Recognition Award Ceremony honors outstanding achievements and contributions within the field of cardiology. This distinguished event celebrates excellence, innovation, and dedication, acknowledging individuals and teams who have significantly advanced interventional cardiology and patient care.
DCB in in-stent restenosis - LIVE Case
07 Apr 2026 – From GulfPCR-GIM 2025
A 60-year-old male with hypertension, type II diabetes, and moderately impaired LV function (45%), has a history of LAD PCI treated with three Cypher stents in 2006. He underwent further treatment for LAD in-stent restenosis in 2012, 2020, and 2022 using a new stent and DCB....
All things vascular
10 Dec 2025 – From GulfPCR-GIM 2025
This session presents a comprehensive exploration of vascular interventions, highlighting advanced techniques such as retrograde tibial artery approaches for long CTO lesions in the superficial femoral artery, catheter-directed thrombectomy for bilateral pulmonary embolism, and innovative endovascular management of pulmonary haemorrhages in Eisenmenger syndrome. Case reports and...
Calcified lesions: caught between a rock and a hard place
10 Dec 2025 – From GulfPCR-GIM 2025
This session focuses on the challenges of treating calcified coronary lesions, emphasizing the use of intravascular ultrasound (IVUS)-guided rotablation and the limitations of rotatripsy in complex bifurcation angioplasty. It covers innovative strategies including off-label Shockwave lithotripsy in stented lesions, management of calcified nodules, and approaches to...
Occlusion myocardial infarction
10 Dec 2025 – From GulfPCR-GIM 2025
This session addresses the evolving paradigm from STEMI to occlusion myocardial infarction, presenting evidence-based advances for recognizing occlusion MI cases that do not meet traditional STEMI criteria. It also offers troubleshooting strategies for managing these complex patients.
PCR Tokyo Valves 2026: Your travel guide featuring upcoming exclusive booking services and special deals.
Percutaneous or surgical management of post-infarction ventricular septal defects: The United Kingdom National Registry
17 Sep 2022
Elad Asher provides his take on the UK National Registry which was presented at the TCT congress 2022 by Joel Peter Giblett on behalf of the UK PIVSD investigators.
Author
EuroPCR 2026 – Long-term mortality following revascularisation for left main disease
20 May 2026
Paris, France, 19−22 May 2026. The EuroPCR Course Directors have selected 3 major late-breaking trials that will be presented for the first time during EuroPCR 2026 and are set to impact practice worldwide. Among them is a meta-analysis of long-term data from 4 randomised trials investigating...
OPTIMUM: Outcomes of Percutaneous RevascularizaTIon for Management of SUrgically Ineligible Patients with Multivessel or Left Main Coronary Artery Disease
04 Nov 2021
Mirvat Alasnag reviews the OPTIMUM trial, presented by David E. Kandzari, which reports outcomes in a subset of patients who are increasingly seen in modern day catheterization laboratories. It is noteworthy that 1 in 5 patients with left main or multivessel disease are considered surgically ineligible.
Author
